Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patients

International Journal of Cancer

Volumn 69, Issue 4, 1996, Pages 283-289

  Yamamoto, Akiyoshi ^a   Shimizu, Eiji ^a   Ogura, Takeshi ^b   Sone, Saburo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TONEYAMA NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ONCOPROTEIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; ONCOGENE MYC; PRIORITY JOURNAL;

AGED; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; BLOTTING, WESTERN; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOSORBENT TECHNIQUES; LUNG NEOPLASMS; MALE; MICE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT FUSION PROTEINS;

EID: 0029800165     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960822)69:4<283::AID-IJC8>3.3.CO;2-D     Document Type: Article

References (22)

1. ANGELOPOULOU, K., DIAMANDIS, E.P., SUTHERLAND, D.J.A., KELLEN, J.A. and BUNTING, P.S., Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers. Int. J. Cancer, 58, 480-487 (1994).
2. BEN-MAHREZ, K., SOROKINE, I., THIERRY, D., KAWASUMI, T., ISHII, S., SALMON, R. and KOHIYAMA, M., Circulating antibodies against c-myc oncogene product in sera of colorectal cancer patients. Int. J. Cancer, 46, 35-38 (1990).
3. BERNARD, O., DRAGO, J. and SHENG, H., L-myc and N-myc influence lineage determination in the central nervous system. Neuron, 9, 1217-1224 (1992).
4. BIRRER, M.J., SEGAL, S., DEGREVE, J.S., KAYE, F., SAUSVILLE, E.A. and MINNA, J.D., L-myc cooperates with ras to transform primary rat embryo fibroblasts. Mol. cell. Biol., 8, 2668-2673 (1988).
5. DAVIDOFF, A.M., IGLEHART, J.D. and MARKS, J.R., Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc. nat. Acad. Sci. (Wash.), 89, 3439-3442 (1992).
6. DONG, X., HAMILTON, K.J., SATOH, M., WANG, J. and REEVES, W.H., Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen. J. exp. Med., 179, 1243-1252 (1994).
7. HUDSON, M. and TURNER-WARWICK, M., Autoantibodies in patients with bronchial carcinoma. Thorax, 30, 367-370 (1975).
8. IKEGAKI, N., MINNA, J., and KENNETT, R.H., The human L-myc gene is expressed as two forms of protein in small cell lung carcinoma cell lines: detection by monoclonal antibodies specific to two myc homology box sequences. EMBO J., 8, 1793-1799 (1989).
9. IMAI, H., NAKANO, Y., KIYOSAWA, K. and TAN, E.M., Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer, 71, 26-35 (1993).
10. KAYE, F., BATTEY, J., NAU, M., BROOKS, B., SHIFTER, E., GREUE, J.D., BIRRER, M., SALISVILLE, E. and MINNA, J., Structure and expression of the human L-myc gene reveal a complex pattern of alternate mRNA processing. Mol. Cell. Biol., 8, 186-195 (1988).
11. LEITZEL, K., TERAMOTO, Y., SAMPSON, E., MAUCERI, J., LANGTON, B.C., DEMERS, L., PODCZASKI, E., HARVEY, H., SHAMBAUGH, S., VOLAS, G., WEAVER, S. and LIPTON, A., Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients. J. clin. Oncol., 10, 1436-1443 (1992).
12. NAU, M.M., BROOKS, B.J., BATTEY, J., SAUSVILLE, E., GAZDAR, A.F., KIRSCH, I.R., MCBRIDE, O.W., BERTNESS, V., HOLLIS, G.F. and MINNA, J.D., L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature (Lond.), 318, 69-73 (1985).
13. PEYRAT, J.P., BONNETERRE, J., LUBIN, R., VANLEMMENS, L., FOURNIER, J. and SOUSSI, T., Prognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer. Lancet, 345, 621-622 (1995).
14. PUPA, S.M., MÉNARD, S., ANDREOLA, S. and COLNAGHI, M.I., Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients. Cancer Res., 53, 5864-5866 (1993).
15. RYGAARD, K., VINDELØV, L.L. and SPANG-THOMSEN, M., Expression of myc family oncoproteins in small-cell lung-cancer cell lines and xenografts. Int. J. Cancer, 54, 144-152 (1993).
16. SCHLICHTHOLZ, B., TRÉDANIEL, J., LUBIN, R., ZALCMAN, G., HIRSCH, A. and SOUSSI, T., Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein. Brit. J. Cancer, 69, 809-816 (1994).
17. SHIRAISHI, M., NOGUCHI, M., SHIMOSATO, Y. and SEKIYA, T., Amplification of protooncogenes in surgical specimens of human lung carcinomas. Cancer Res., 49, 6474-6479 (1989).
18. SMITH, D.B. and JOHNSON, K.S., Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione Stransferase. Gene, 67, 31-40 (1988).
19. SOROKINE, I., BEN-MAHREZ, K., BRACONE, A., THIERRY, D., ISHII, S., IMAMOTO, F. and KOHIYAMA, M., Presence of circulating anti-c-myb oncogene product antibodies in human sera. Int. J. Cancer, 47, 665-669 (1991).
20. SOUSSI, T., LEGROS, Y., LUBIN, R., ORY, K. and SCHLICHTHOLZ, B., Multifactorial analysis of p53 alteration in human cancer: a review. Int. J. Cancer, 57, 1-9 (1994).
21. TAKAHASHI, M., CHEN, W., BYRD, D.R., DISIS, M.L., HUSEBY, E.S., QIN, H., MCCAHILL, L., NELSON, H., SHIMADA, H., OKUNO, K., YASUTOMI, M., PEACE, D.J. and CHEEVER, M.A., Antibody to ras proteins in patients with colon cancer. Clin. Cancer Res., 1, 1071-1077 (1995).
22. ZlMMERMAN, K.A., YANCOPOULOS, G.D., COLLUM, R.G., SMITH, R.K., KOHL, N.E., DENIS, K.A., NAU, M.M., WITTE, O.N., TORANALLERAND, D., GEE, C.E., MINNA, J.D. and ALT, F.W., Differential expression of myc family genes during murine development. Nature (Lond.), 319, 780-783 (1986).